Cargando…
Genetic Characterization of Cancer of Unknown Primary Using Liquid Biopsy Approaches
Cancers of unknown primary (CUPs) comprise a heterogeneous group of rare metastatic tumors whose primary site cannot be identified after extensive clinical–pathological investigations. CUP patients are generally treated with empirical chemotherapy and have dismal prognosis. As recently reported, CUP...
Autores principales: | Laprovitera, Noemi, Salamon, Irene, Gelsomino, Francesco, Porcellini, Elisa, Riefolo, Mattia, Garonzi, Marianna, Tononi, Paola, Valente, Sabrina, Sabbioni, Silvia, Fontana, Francesca, Manaresi, Nicolò, D’Errico, Antonia, Pantaleo, Maria A., Ardizzoni, Andrea, Ferracin, Manuela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222689/ https://www.ncbi.nlm.nih.gov/pubmed/34178989 http://dx.doi.org/10.3389/fcell.2021.666156 |
Ejemplares similares
-
MicroRNA expression profiling with a droplet digital PCR assay enables molecular diagnosis and prognosis of cancers of unknown primary
por: Laprovitera, Noemi, et al.
Publicado: (2021) -
Cancer of Unknown Primary: Challenges and Progress in Clinical Management
por: Laprovitera, Noemi, et al.
Publicado: (2021) -
KRAS and ERBB-family genetic alterations affect response to PD-1
inhibitors in metastatic nonsquamous NSCLC
por: Cinausero, Marika, et al.
Publicado: (2019) -
Capmatinib-Induced Liver Injury as Emerging Toxicity of MET Inhibitors in Patients With NSCLC Pretreated With Immune Checkpoint Inhibitors
por: Sisi, Monia, et al.
Publicado: (2023) -
Cancer Site-Specific Multiple microRNA Quantification by Droplet Digital PCR
por: Laprovitera, Noemi, et al.
Publicado: (2018)